Baseline characteristics and intraoperative details by treatment group
| Baseline characteristics | Placebo | Elafin |
|---|---|---|
| Age | 63.6±8.4 | 63.9±7.7 |
| Two-vessel coronary disease | 12(27.9) | 11(25.0) |
| Three-vessel coronary disease | 31(72.1) | 33(75.0) |
| Creatinine (mg/dL) | 0.92±0.18 | 0.94±0.23 |
| Diabetes mellitus | 9 (20.9) | 11 (25.0) |
| Surgeon A | 16 (37.2) | 18 (40.9) |
| Surgeon B | 27 (62.8) | 26 (59.1) |
| Male gender | 36 (83.7) | 38 (86.4) |
| EuroSCORE | 2.21±1.73 | 2.64±2.06 |
| Intraoperative details | ||
| Number of bypass grafts | ||
| One | 1 | 2 |
| Two | 19 | 14 |
| Three | 14 | 22 |
| Four | 9 | 5 |
| Five | 0 | 1 |
| Cardiopulmonary bypass time (min) | 77±26 | 78±26 |
| Cross clamp time (min) | 45±15 | 47±16 |
Data are number of patients (%) or mean±SD.